Little, R. F., Othus, M., Assouline, S., Ansher, S., Atallah, E. L., Lindsley, R. C., … Erba, H. P. (2022). Umbrella Trial in Myeloid Malignancies: The Myelomatch National Clinical Trials Network Precision Medicine Initiative. In Blood (Vol. 140, pp. 9057–9060). American Society of Hematology. https://doi.org/10.1182/blood-2022-169307

Little, Richard F., Megan Othus, Sarit Assouline, Sherry Ansher, Ehab L. Atallah, R Coleman Lindsley, Boris Freidlin, et al. “Umbrella Trial in Myeloid Malignancies: The Myelomatch National Clinical Trials Network Precision Medicine Initiative.” In Blood, 140:9057–60. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-169307.

Little RF, Othus M, Assouline S, Ansher S, Atallah EL, Lindsley RC, et al. Umbrella Trial in Myeloid Malignancies: The Myelomatch National Clinical Trials Network Precision Medicine Initiative. In: Blood. American Society of Hematology; 2022. p. 9057–60.

Little, Richard F., et al. “Umbrella Trial in Myeloid Malignancies: The Myelomatch National Clinical Trials Network Precision Medicine Initiative.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 9057–60. Crossref, doi:10.1182/blood-2022-169307.

Little RF, Othus M, Assouline S, Ansher S, Atallah EL, Lindsley RC, Freidlin B, Gore SD, Harris L, Hourigan CS, Ivy SP, Jiwani S, Langan E, Luger SM, Michaelis LC, Odenike O, Patton D, Perales M-A, Radich JP, Ramineni B, Salk JJ, Stiff P, Stock W, Stone RM, Uy GL, Williams PM, Wood BL, Worthington KH, Yee LM, Zeidan AM, Zhang J, Litzow MR, Erba HP. Umbrella Trial in Myeloid Malignancies: The Myelomatch National Clinical Trials Network Precision Medicine Initiative. Blood. American Society of Hematology; 2022. p. 9057–9060.